Skip to main content
Log in

Costs and use of PETN vs ISDN for diabetics in Germany

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Icks A, Haastert B, Rathmann W, Schröder-Bernhardi D, Giani G.Cost comparison analysis: pentaerythrithyl tetranitrate (PETN) and isosorbide dinitrate (ISDN) prescribed to diabetic patients in primary care practices in Germany. International Journal of Clinical Pharmacology and Therapeutics 45: 516-523, No. 9, Sep 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costs and use of PETN vs ISDN for diabetics in Germany. Pharmacoecon. Outcomes News 539, 9 (2007). https://doi.org/10.2165/00151234-200705390-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705390-00019

Keywords

Navigation